Complete Filing Data
Lemonade, Inc. reported Stockholders Equity of $533.60 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Lemonade, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$165.5M | -$202.2M | -$236.9M | -$297.8M | -$241.3M | -$122.3M | -$108.5M | -$52.9M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $12.5M | $2.9M | $18.6M | -$24.2M | -$5.2M | $1.7M | $100.0K | |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $2.4M | $5.6M | $18.6M | -$18.4M | -$5.7M | $100.0K | $100.0K | $0.00 |
| Selling And Marketing Expense | $224.4M | $166.3M | $101.9M | $138.3M | $141.6M | $80.4M | $88.5M | $41.7M |
| Revenues | $737.9M | $526.5M | $429.8M | $256.7M | $128.4M | $94.4M | $67.3M | $22.5M |
| Research And Development Expense | $93.9M | $85.8M | $88.8M | $79.6M | $51.8M | $19.4M | $9.8M | $4.7M |
| Income Tax Expense Benefit | $4.6M | -$1.7M | $7.1M | $3.0M | $7.7M | $1.5M | $600.0K | $300.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$160.9M | -$203.9M | -$229.8M | -$294.8M | -$233.6M | -$120.8M | -$107.9M | -$52.6M |
| General And Administrative Expense | $139.8M | $124.5M | $129.3M | $122.3M | $72.6M | $46.3M | $21.5M | $9.3M |
| Comprehensive Income Net Of Tax | -$153.0M | -$199.3M | -$218.3M | -$322.0M | -$246.5M | -$120.6M | -$108.4M | -$52.9M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $10.1M | -$2.7M | $0.00 | -$5.8M | $500.0K | $1.6M | $0.00 | $0.00 |
| Income Taxes Paid | $2.5M | $2.5M | $700.0K | $3.4M | $3.2M | $1.6M | $500.0K | $200.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$37.5M | -$43.9M | -$62.4M | -$67.7M | -$57.2M | -$47.3M | -$61.5M | -$67.2M | -$65.8M | -$91.4M | -$67.9M | -$74.8M | -$66.4M | -$55.6M | -$49.0M | -$30.9M | -$21.0M | -$36.5M | -$31.1M | -$23.1M | -$21.6M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $1.0M | $7.6M | $2.7M | $8.5M | $600.0K | -$200.0K | $1.9M | $1.3M | $5.3M | -$6.5M | -$10.0M | -$15.4M | -$800.0K | -$100.0K | -$800.0K | $400.0K | $200.0K | $0.00 | -$100.0K | $0.00 | $0.00 |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $600.0K | $400.0K | $1.2M | $5.4M | $1.3M | $700.0K | $2.9M | $1.2M | $6.0M | -$5.0M | -$4.5M | -$14.3M | -$800.0K | -$200.0K | $100.0K | $400.0K | $200.0K | $0.00 | -$100.0K | $0.00 | $0.00 |
| Selling And Marketing Expense | $57.4M | $59.6M | $43.2M | $51.4M | $36.8M | $30.4M | $24.4M | $24.8M | $28.2M | $35.8M | $37.0M | $38.3M | $42.2M | $33.1M | $29.1M | $22.2M | $16.1M | $19.2M | $27.5M | $19.0M | |
| Revenues | $194.5M | $164.1M | $151.2M | $136.6M | $122.0M | $119.1M | $114.5M | $104.6M | $95.2M | $74.0M | $50.0M | $44.3M | $35.7M | $28.2M | $23.5M | $17.8M | $29.9M | $26.2M | $19.0M | $13.8M | |
| Research And Development Expense | $24.7M | $22.4M | $22.0M | $21.9M | $21.2M | $20.9M | $21.8M | $24.1M | $21.8M | $21.4M | $17.8M | $16.9M | $14.3M | $14.0M | $7.1M | $5.3M | $4.2M | $3.5M | $2.8M | $2.1M | |
| Income Tax Expense Benefit | $1.2M | $1.3M | $1.0M | $1.9M | $2.1M | $2.1M | $1.9M | $1.3M | $1.1M | $2.3M | $2.9M | $2.2M | $2.2M | $2.7M | $900.0K | $400.0K | $300.0K | $300.0K | $100.0K | $100.0K | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$36.3M | -$42.6M | -$61.4M | -$65.8M | -$55.1M | -$45.2M | -$59.6M | -$65.9M | -$64.7M | -$89.1M | -$65.0M | -$72.6M | -$64.2M | -$52.9M | -$48.1M | -$30.5M | -$20.7M | -$36.2M | -$31.0M | -$23.0M | |
| General And Administrative Expense | $35.0M | $25.8M | $35.9M | $31.4M | $29.8M | $29.8M | $36.9M | $30.7M | $32.7M | $40.5M | $22.4M | $28.2M | $19.6M | $15.8M | $14.1M | $10.6M | $5.8M | $18.2M | $4.8M | $3.6M | |
| Comprehensive Income Net Of Tax | -$36.5M | -$36.3M | -$59.7M | -$59.2M | -$56.6M | -$47.5M | -$59.6M | -$65.9M | -$60.5M | -$97.9M | -$77.9M | -$90.2M | -$67.2M | -$55.5M | -$48.2M | -$30.5M | -$20.8M | -$36.5M | -$31.2M | -$23.1M | |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $400.0K | $7.2M | $1.5M | $3.1M | -$700.0K | -$900.0K | -$1.0M | $100.0K | -$700.0K | -$1.5M | -$5.5M | -$1.1M | $0.00 | $300.0K | $700.0K | $0.00 | $0.00 | $0.00 | |||
| Income Taxes Paid | $300.0K | $300.0K | $200.0K | $1.1M | $600.0K | $500.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $533.6M | $593.4M | $708.9M | $866.8M | $988.2M | $541.0M | -$182.5M | -$79.1M | -$28.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $396.8M | $385.7M | $271.5M | $286.5M | $270.6M | $571.4M | $270.3M | $102.4M | $16.9M |
| Liability For Claims And Claims Adjustment Expense | $303.1M | $298.1M | $262.3M | $256.2M | $97.9M | $46.3M | $28.2M | $13.1M | |
| Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 | $347.0M | $277.0M | $280.4M | $167.3M | $71.9M | $54.7M | $45.8M | $15.2M | |
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $0.00 | $480.2M | $180.8M | $60.4M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $11.1M | $114.2M | -$15.0M | $15.9M | -$300.8M | $301.1M | $167.9M | $85.5M | |
| Deferred Policy Acquisition Costs | $12.1M | $12.2M | $8.8M | $6.9M | $6.2M | $3.5M | $1.8M | $600.0K | |
| Accretion Amortization Of Discounts And Premiums Investments | $6.1M | $2.6M | -$6.7M | $4.2M | $400.0K | $500.0K | $0.00 | ||
| Retained Earnings Accumulated Deficit | -$1.46B | -$1.30B | -$1.10B | -$859.7M | -$561.9M | -$320.6M | -$198.3M | ||
| Property Plant And Equipment Net | $15.8M | $16.1M | $17.4M | $19.6M | $11.7M | $5.7M | $3.1M | ||
| Premiums Receivable At Carrying Value | $402.3M | $301.2M | $222.0M | $179.6M | $127.0M | $86.1M | $54.1M | ||
| Premiums Receivable Allowance For Doubtful Accounts | $4.1M | $2.8M | $2.5M | $2.7M | $1.6M | $500.0K | $200.0K | ||
| Other Assets | $47.4M | $42.4M | $63.8M | $75.2M | $53.2M | $14.5M | $2.5M | ||
| Liabilities And Stockholders Equity | $1.93B | $1.85B | $1.63B | $1.69B | $1.51B | $828.7M | $414.3M | ||
| Liabilities | $1.39B | $1.26B | $924.4M | $823.9M | $522.3M | $287.7M | $116.6M | ||
| Investments | $722.9M | $634.9M | $673.2M | $750.1M | $801.8M | $6.6M | $60.6M | ||
| Common Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Assets | $1.93B | $1.85B | $1.63B | $1.69B | $1.51B | $828.7M | $414.3M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $6.4M | -$6.1M | -$9.0M | -$27.6M | -$3.4M | $1.8M | $100.0K | ||
| Accrued Liabilities And Other Liabilities | $121.8M | $105.7M | $99.5M | $84.5M | $57.4M | $18.7M | $19.7M | ||
| Accounts Payable Trade Current And Noncurrent | $500.0K | $4.5M | $600.0K | $1.1M | $1.0M | $1.4M | $700.0K | ||
| Short Term Investments | $14.1M | $27.5M | $45.8M | $99.8M | $110.4M | $0.00 | $54.7M | ||
| Funds Held Under Reinsurance Agreements Liability | $169.5M | $219.6M | $128.8M | $136.0M | $103.1M | $62.1M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $516.2M | $527.1M | $545.5M | $593.0M | $635.2M | $676.4M | $726.9M | $771.0M | $821.8M | $906.8M | $849.1M | $912.7M | $1.05B | $1.10B | $1.14B | $569.0M | -$221.6M | -$204.6M | -$152.2M | -$122.7M | -$100.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $355.5M | $386.0M | $319.7M | $337.8M | $349.7M | $285.2M | $238.1M | $193.8M | $254.8M | $225.0M | $199.6M | $235.0M | $319.6M | $1.09B | $1.17B | $575.7M | $258.8M | $274.2M | $303.2M | $226.9M | |
| Liability For Claims And Claims Adjustment Expense | $312.1M | $309.8M | $307.3M | $294.2M | $282.2M | $264.0M | $255.1M | $255.6M | $245.2M | $220.6M | $122.9M | $107.6M | $74.0M | $64.7M | $62.2M | $39.7M | $35.3M | $31.8M | $24.6M | $20.7M | |
| Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 | $89.6M | $77.5M | $85.4M | $77.9M | $70.5M | $65.9M | $75.9M | $75.9M | $63.6M | $53.3M | $28.1M | $24.4M | $17.5M | $13.0M | $16.5M | $6.7M | $20.5M | $18.2M | $12.6M | $9.9M | |
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $0.00 | $0.00 | $480.2M | $480.2M | $480.2M | $355.2M | $180.8M | ||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$66.0M | $13.7M | -$31.7M | -$35.6M | $603.3M | $3.9M | |||||||||||||||
| Deferred Policy Acquisition Costs | $13.5M | $12.6M | $11.4M | $11.9M | $11.2M | $9.8M | $8.1M | $6.6M | $6.9M | $7.6M | $7.4M | $6.7M | $6.0M | $4.9M | $4.1M | $3.3M | $2.5M | ||||
| Accretion Amortization Of Discounts And Premiums Investments | $1.5M | $1.3M | -$200.0K | -$2.5M | $0.00 | $200.0K | |||||||||||||||
| Retained Earnings Accumulated Deficit | -$1.44B | -$1.41B | -$1.36B | -$1.27B | -$1.20B | -$1.14B | -$1.05B | -$992.7M | -$925.5M | -$796.0M | -$704.6M | -$636.7M | -$491.6M | -$425.2M | -$369.6M | -$286.7M | -$255.8M | ||||
| Property Plant And Equipment Net | $15.3M | $16.0M | $16.2M | $16.0M | $16.3M | $17.2M | $17.4M | $19.0M | $19.8M | $19.1M | $13.2M | $13.0M | $10.8M | $8.8M | $6.9M | $5.1M | $4.3M | ||||
| Premiums Receivable At Carrying Value | $395.3M | $346.7M | $317.8M | $297.7M | $259.7M | $237.1M | $223.2M | $197.8M | $185.0M | $187.7M | $147.6M | $135.6M | $129.2M | $108.1M | $98.5M | $82.8M | $64.9M | ||||
| Premiums Receivable Allowance For Doubtful Accounts | $3.1M | $2.8M | $2.8M | $2.8M | $2.5M | $2.5M | $2.5M | $2.4M | $2.7M | $2.7M | $2.2M | $1.9M | $1.0M | $700.0K | $500.0K | $400.0K | $400.0K | ||||
| Other Assets | $35.7M | $40.3M | $39.4M | $39.4M | $37.4M | $41.1M | $67.6M | $70.3M | $74.5M | $73.1M | $53.3M | $57.4M | $29.4M | $16.0M | $16.0M | $13.9M | $6.0M | ||||
| Liabilities And Stockholders Equity | $1.92B | $1.93B | $1.86B | $1.82B | $1.71B | $1.65B | $1.65B | $1.61B | $1.64B | $1.71B | $1.46B | $1.50B | $1.52B | $1.49B | $1.48B | $831.5M | $399.9M | ||||
| Liabilities | $1.40B | $1.41B | $1.31B | $1.23B | $1.08B | $970.0M | $920.7M | $842.1M | $819.4M | $806.1M | $611.8M | $582.7M | $473.7M | $385.7M | $333.8M | $262.5M | $141.3M | ||||
| Investments | $705.3M | $645.8M | $676.1M | $640.8M | $581.2M | $641.9M | $706.8M | $748.1M | $737.9M | $835.9M | $760.0M | $777.9M | $805.1M | $71.2M | $6.5M | $21.7M | $36.6M | ||||
| Common Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Assets | $1.92B | $1.93B | $1.86B | $1.82B | $1.71B | $1.65B | $1.65B | $1.61B | $1.64B | $1.71B | $1.46B | $1.50B | $1.52B | $1.49B | $1.48B | $831.5M | $399.9M | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $5.2M | $4.2M | -$3.4M | -$100.0K | -$8.6M | -$9.2M | -$19.1M | -$21.0M | -$22.3M | -$35.3M | -$28.8M | -$18.8M | $100.0K | $900.0K | $1.0M | $700.0K | $300.0K | ||||
| Accrued Liabilities And Other Liabilities | $107.0M | $124.2M | $110.0M | $123.5M | $121.2M | $100.5M | $93.1M | $79.8M | $85.0M | $90.3M | $63.7M | $68.3M | $35.5M | $28.0M | $19.8M | $54.1M | $18.5M | ||||
| Accounts Payable Trade Current And Noncurrent | $5.1M | $2.3M | $3.4M | $1.0M | $600.0K | $600.0K | $2.7M | $700.0K | $1.9M | $1.5M | $1.3M | $2.6M | $3.0M | $1.3M | $1.0M | $1.0M | $600.0K | ||||
| Short Term Investments | $23.5M | $21.3M | $20.5M | $31.1M | $44.0M | $22.1M | $73.4M | $71.3M | $89.4M | $142.8M | $85.9M | $83.2M | $107.5M | $15.0M | $29.9M | ||||||
| Funds Held Under Reinsurance Agreements Liability | $202.5M | $240.1M | $225.1M | $189.3M | $157.3M | $132.4M | $131.1M | $129.3M | $129.1M | $131.7M | $119.2M | $108.2M | $97.1M | $77.6M | $66.0M | $52.4M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $61.3M | $64.5M | $59.9M | $59.3M | $44.1M | $10.6M | $4.3M | $2.1M |
| Proceeds From Stock Options Exercised | $31.9M | $19.3M | $500.0K | $3.6M | $9.3M | $1.8M | $700.0K | $100.0K |
| Proceeds From Sale And Maturity Of Marketable Securities | $41.6M | $77.5M | $143.5M | $224.5M | $20.2M | $70.0M | $21.0M | $20.9M |
| Proceeds From Sale And Maturity Of Available For Sale Securities | $383.1M | $336.3M | $349.6M | $138.0M | $27.2M | $2.3M | $1.0M | $0.00 |
| Payments To Acquire Property Plant And Equipment | $9.4M | $9.4M | $9.2M | $10.1M | $9.4M | $4.4M | $2.7M | $700.0K |
| Payments To Acquire Marketable Securities | $27.7M | $58.1M | $71.5M | $136.7M | $130.8M | $14.9M | $69.2M | $13.8M |
| Payments To Acquire Available For Sale Securities Debt | $476.7M | $305.7M | $323.7M | $133.4M | $712.0M | $2.9M | $3.5M | $0.00 |
| Net Cash Provided By Used In Operating Activities | -$16.5M | -$11.4M | -$119.1M | -$163.0M | -$144.6M | -$91.7M | -$78.1M | -$40.8M |
| Net Cash Provided By Used In Investing Activities | -$89.1M | $40.6M | $88.7M | $181.1M | -$804.8M | $50.1M | -$54.0M | $6.4M |
| Net Cash Provided By Used In Financing Activities | $106.6M | $87.7M | $15.4M | $3.6M | $649.6M | $341.1M | $300.1M | $119.9M |
| Increase Decrease In Unearned Premiums Net | -$122.0M | -$101.3M | -$65.7M | -$65.1M | -$83.9M | -$55.8M | -$40.3M | -$21.4M |
| Increase Decrease In Reinsurance Recoverable | -$17.0M | $32.0M | -$18.4M | $52.6M | $40.8M | $28.7M | $8.5M | $8.9M |
| Increase Decrease In Prepaid Reinsurance Premiums | -$105.7M | $57.3M | $31.8M | $14.9M | $58.3M | $90.3M | -$500.0K | $800.0K |
| Increase Decrease In Premiums Receivable | $123.2M | $90.2M | $50.5M | $43.8M | $47.2M | $34.2M | $29.1M | $20.0M |
| Increase Decrease In Other Operating Assets | $8.2M | -$21.2M | -$8.9M | $7.0M | $38.6M | $12.0M | $1.1M | $400.0K |
| Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve | $5.0M | $35.8M | $6.1M | $74.0M | $51.6M | $18.1M | $15.1M | $11.0M |
| Increase Decrease In Deferred Policy Acquisition Costs | -$100.0K | $3.4M | $1.9M | $800.0K | $2.7M | $1.7M | $1.2M | $500.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $21.5M | $6.2M | $15.0M | $4.9M | $38.6M | $2.9M | $9.9M | $7.7M |
| Increase Decrease In Accounts Payable | -$4.0M | $3.9M | -$500.0K | -$700.0K | -$400.0K | $700.0K | -$800.0K | $200.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $10.1M | -$2.7M | $0.00 | -$5.8M | -$1.0M | $1.6M | -$100.0K | $0.00 |
| Increase Decrease In Reinsurance Payables | -$50.1M | $90.8M | -$7.2M | $32.9M | $41.0M | $62.1M | $0.00 | $0.00 |
| Increase Decrease In Deferred Ceding Commissions | -$27.4M | $24.2M | $1.7M | $3.2M | $14.1M | $22.4M | $0.00 | |
| Increase Decrease In Ceded Premiums Payable | $100.0K | $600.0K | $4.8M | -$12.4M | $5.7M | $9.1M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $10.3M | $14.9M | $15.4M | $14.1M | $6.1M | $2.2M |
| Proceeds From Stock Options Exercised | $1.5M | $100.0K | $100.0K | $600.0K | $6.1M | $0.00 |
| Proceeds From Sale And Maturity Of Marketable Securities | $9.4M | $29.3M | $36.6M | $44.7M | $0.00 | $40.0M |
| Proceeds From Sale And Maturity Of Available For Sale Securities | $30.2M | $58.7M | $106.9M | $9.2M | $0.00 | $1.4M |
| Payments To Acquire Property Plant And Equipment | $2.3M | $2.5M | $2.7M | $2.8M | $2.0M | $700.0K |
| Payments To Acquire Marketable Securities | $2.0M | $5.4M | $23.2M | $17.9M | $0.00 | $14.9M |
| Payments To Acquire Available For Sale Securities Debt | $75.6M | $49.2M | $102.3M | $29.1M | $0.00 | $2.3M |
| Net Cash Provided By Used In Operating Activities | -$47.2M | -$29.8M | -$46.4M | -$39.5M | -$40.3M | -$19.4M |
| Net Cash Provided By Used In Investing Activities | -$40.3M | $30.9M | $15.3M | $4.1M | -$2.0M | $23.5M |
| Net Cash Provided By Used In Financing Activities | $20.0M | $13.5M | $100.0K | $600.0K | $646.4M | $0.00 |
| Increase Decrease In Unearned Premiums Net | -$21.2M | -$17.6M | -$9.8M | -$14.7M | -$19.7M | -$7.6M |
| Increase Decrease In Reinsurance Recoverable | $11.9M | $31.7M | -$3.1M | $22.7M | $16.8M | $2.1M |
| Increase Decrease In Prepaid Reinsurance Premiums | $9.9M | $8.2M | -$4.7M | $7.1M | $13.1M | -$900.0K |
| Increase Decrease In Premiums Receivable | $21.1M | $18.3M | $7.7M | $10.6M | $13.3M | $3.4M |
| Increase Decrease In Other Operating Assets | -$2.8M | -$22.7M | -$700.0K | $4.2M | $1.6M | $1.6M |
| Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve | $9.2M | $1.7M | -$11.0M | $9.7M | $15.9M | $3.6M |
| Increase Decrease In Deferred Policy Acquisition Costs | -$800.0K | $1.0M | $0.00 | $500.0K | $600.0K | $200.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $4.1M | $1.0M | $600.0K | $10.8M | $1.2M | -$2.6M |
| Increase Decrease In Accounts Payable | -$1.1M | $0.00 | $800.0K | $1.6M | -$400.0K | $200.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.5M | -$900.0K | -$700.0K | -$800.0K | -$800.0K | -$200.0K |
| Increase Decrease In Reinsurance Payables | $5.5M | $3.6M | -$6.9M | $5.1M | $3.9M | $0.00 |
| Increase Decrease In Deferred Ceding Commissions | -$4.6M | $4.9M | -$200.0K | $2.3M | $3.6M | $0.00 |
| Increase Decrease In Ceded Premiums Payable | $2.4M | $3.4M | $2.5M | $16.1M | $2.3M | -$200.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$2.24 | -$2.85 | -$3.40 | -$4.59 | -$3.94 | -$3.63 | -$9.75 | -$4.84 | |
| Weighted Average Number Of Shares Outstanding Basic | 73.9M | 71.0M | 69.7M | 64.9M | 61.2M | 33.7M | 11.1M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 73.9M | 71.0M | 69.7M | 64.9M | 61.2M | 33.7M | 11.1M | ||
| Earnings Per Share Basic | $-2.24 | $-2.85 | $-3.40 | $-4.59 | $-3.94 | $-3.63 | $-9.75 | ||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 52.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 | 31.6M | 24.4M | 15.7M | |||
| Common Stock Shares Outstanding | 75.9M | 72.7M | 70.2M | 69.3M | 61.7M | 56.8M | 11.3M | ||
| Common Stock Shares Issued | 75.9M | 72.7M | 70.2M | 69.3M | 61.7M | 56.8M | 11.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.51 | -$0.60 | -$0.86 | -$0.95 | -$0.81 | -$0.67 | -$0.88 | -$0.97 | -$0.95 | -$1.37 | -$1.10 | -$1.21 | -$1.08 | -$0.90 | -$0.81 | -$0.57 | -$1.77 | -$3.16 | -$2.78 | -$2.09 | |
| Weighted Average Number Of Shares Outstanding Basic | 74.2M | 73.4M | 72.9M | 71.1M | 70.7M | 70.3M | 69.8M | 69.5M | 69.3M | 66.9M | 61.8M | 61.7M | 61.6M | 61.4M | 60.2M | 54.0M | 11.9M | 11.5M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 74.2M | 73.4M | 72.9M | 71.1M | 70.7M | 70.3M | 69.8M | 69.5M | 69.3M | 66.9M | 61.8M | 61.7M | 61.6M | 61.4M | 60.2M | 54.0M | 11.9M | 11.5M | |||
| Earnings Per Share Basic | $-0.51 | $-0.60 | $-0.86 | $-0.95 | $-0.81 | $-0.67 | $-0.88 | $-0.97 | $-0.95 | $-1.37 | $-1.10 | $-1.21 | $-1.08 | $-0.90 | $-0.81 | $-0.57 | $-1.77 | $-3.16 | |||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | |||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 31.6M | 31.6M | 31.6M | 28.60T | 24.4M | ||||||||||||
| Common Stock Shares Outstanding | 74.7M | 73.8M | 73.2M | 71.4M | 71.0M | 70.5M | 69.9M | 69.7M | 69.4M | 69.1M | 61.9M | 61.8M | 61.6M | 61.5M | 61.4M | 56.6M | 12.4M | ||||
| Common Stock Shares Issued | 74.7M | 73.8M | 73.2M | 71.4M | 71.0M | 70.5M | 69.9M | 69.7M | 69.4M | 69.1M | 61.9M | 61.8M | 61.6M | 61.5M | 61.4M | 56.6M | 12.4M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $61.3M | $64.5M | $59.9M | $59.3M | $44.1M | $10.6M | $4.3M | $2.1M |
| Premiums Earned Net | $536.3M | $370.6M | $315.2M | $172.4M | $77.0M | $77.3M | $63.8M | $21.2M |
| Other Insurance Expense | $93.7M | $76.8M | $59.2M | $44.0M | $24.1M | $14.4M | $9.6M | $4.2M |
| Net Investment Income | $37.8M | $34.0M | $24.7M | $8.4M | $1.9M | $1.5M | $3.4M | $1.3M |
| Insurance Commissions And Fees | $41.1M | $30.8M | $20.1M | $11.8M | $4.6M | $300.0K | $100.0K | $0.00 |
| Benefits Losses And Expenses | $898.8M | $730.4M | $659.6M | $551.5M | $362.0M | $215.2M | $175.2M | $75.1M |
| Ceded Commission Income | $122.7M | $91.1M | $69.8M | $64.1M | $44.9M | $15.3M | $0.00 | $0.00 |
| Stock Issued During Period Value Stock Options Exercised | $19.3M | $500.0K | $3.6M | $9.3M | $1.8M | $500.0K | ||
| Unearned Premiums | $577.0M | $455.0M | $353.7M | $288.0M | $207.7M | $123.8M | $68.0M | |
| Reinsurance Recoverables On Paid And Unpaid Losses | $153.4M | $170.4M | $138.4M | $156.8M | $89.8M | $49.0M | $20.3M | |
| Prepaid Reinsurance Premiums | $147.9M | $253.6M | $196.3M | $164.5M | $149.6M | $91.3M | $1.0M | |
| Additional Paid In Capital | $1.99B | $1.90B | $1.81B | $1.75B | $1.55B | $859.8M | $15.7M | |
| Provision For Doubtful Accounts | $22.1M | $11.0M | $8.1M | $8.7M | $6.2M | $2.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $17.1M | $15.4M | $10.3M | $16.9M | $15.4M | $14.9M | $15.4M | $14.8M | $15.4M | $15.6M | $13.9M | $14.1M | $12.7M | $11.9M | $6.1M | $2.7M | $2.4M | $2.2M | $1.5M | $400.0K | $400.0K |
| Premiums Earned Net | $140.0M | $112.5M | $104.3M | $95.7M | $89.3M | $84.4M | $86.6M | $76.5M | $68.2M | $50.6M | $31.2M | $27.4M | $21.5M | $16.3M | $13.8M | $10.5M | $29.2M | $25.3M | $17.8M | $13.3M | |
| Other Insurance Expense | $24.1M | $21.4M | $26.1M | $19.8M | $18.8M | $17.3M | $15.1M | $15.0M | $13.6M | $12.1M | $9.7M | $9.1M | $6.3M | $5.2M | $4.8M | $3.5M | $4.0M | $3.3M | $2.3M | $2.2M | |
| Net Investment Income | $9.7M | $9.4M | $9.5M | $8.9M | $8.1M | $7.6M | $7.0M | $5.6M | $5.0M | $2.6M | $1.2M | $900.0K | $600.0K | $200.0K | $200.0K | $200.0K | $200.0K | $900.0K | $1.1M | $500.0K | |
| Insurance Commissions And Fees | $12.6M | $11.8M | $10.5M | $8.0M | $8.1M | $6.1M | $4.2M | $5.0M | $4.8M | $3.9M | $2.1M | $2.0M | $1.3M | $1.1M | $500.0K | $100.0K | $100.0K | $0.00 | $100.0K | $0.00 | |
| Benefits Losses And Expenses | $230.8M | $206.7M | $212.6M | $202.4M | $177.1M | $164.3M | $174.1M | $170.5M | $159.9M | $163.1M | $115.0M | $116.9M | $99.9M | $81.1M | $71.6M | $48.3M | $50.6M | $62.4M | $50.0M | $36.8M | |
| Ceded Commission Income | $32.2M | $30.4M | $26.9M | $24.0M | $16.5M | $21.0M | $16.7M | $17.5M | $17.2M | $16.9M | $15.5M | $14.0M | $12.3M | $10.6M | $9.0M | $7.0M | $400.0K | $0.00 | $0.00 | $0.00 | |
| Stock Issued During Period Value Stock Options Exercised | $2.3M | $400.0K | $600.0K | $900.0K | $1.7M | $6.1M | $200.0K | $100.0K | $100.0K | $300.0K | |||||||||||
| Unearned Premiums | $567.9M | $509.5M | $476.2M | $453.8M | $397.6M | $371.3M | $355.6M | $315.9M | $297.8M | $294.1M | $241.6M | $222.4M | $203.2M | $166.0M | $143.5M | $115.3M | $86.9M | ||||
| Reinsurance Recoverables On Paid And Unpaid Losses | $167.7M | $177.8M | $182.3M | $189.9M | $203.0M | $170.1M | $144.6M | $164.4M | $153.7M | $136.3M | $110.3M | $112.5M | $70.8M | $64.7M | $65.8M | $42.2M | $26.2M | ||||
| Prepaid Reinsurance Premiums | $203.4M | $281.6M | $263.5M | $254.7M | $218.2M | $204.5M | $197.6M | $166.6M | $159.8M | $181.6M | $168.9M | $156.7M | $150.2M | $120.3M | $104.4M | $86.2M | $0.00 | ||||
| Additional Paid In Capital | $1.95B | $1.93B | $1.91B | $1.86B | $1.84B | $1.83B | $1.80B | $1.78B | $1.77B | $1.74B | $1.58B | $1.57B | $1.54B | $1.53B | $1.51B | $855.0M | $33.9M | ||||
| Provision For Doubtful Accounts | $4.5M | $3.2M | $2.3M | $2.0M | $900.0K | $400.0K |
Most recent annual filing with the SEC: February 25, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.